| 产品详情 |
| Edit |   |
|---|
| Product Name | Miransertib |
|---|
| Description | Miransertib is an allosteric, pan-Akt inhibitor (IC50s = 5.0, 4.5, and 16 nM for Akt1, Akt2, and Akt3, respectively). It is selective for Akt isoforms over a panel of 303 other kinases. It binds to and inhibits the activity of AKT in a non-ATP competitive manner, which may result in the inhibition of the PI3K/AKT signaling pathway. MW: 432.53. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine; ARQ-092 |
|---|
| Gene, Accession, CAS # | CAS: 1313881-70-7 |
|---|
| Catalog # | B1931-25 |
|---|
| Price | |
|---|
| Order / More Info | Miransertib from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|